Searchable abstracts of presentations at key conferences in endocrinology

ea0016p52 | Adrenal | ECE2008

Relation between serum adiponectin level, subclinical Cushing's syndrome and non-functional adrenal incidentaloma

Unal Asli Dogruk , Ayturk Semra , Kemal Yasemin , Tutuncu Neslihan Bascil , Demirag Nilgun Guvener

In this study we compared plasma adiponectin levels between patients with non-functional adrenal incidentaloma and subclinical Cushing’s syndrome. Our aims were to determine whether there was any difference of plasma adiponectin levels, any relation between cardiovasculer risk factors and to investigate the importance of adiponectin levels in subclinical Cushing’s syndrome patients according to non-functional adrenal incidentaloma patients. The patients referred from...

ea0016p690 | Thyroid | ECE2008

Clinicopathological characteristics of thyroid cancer in patients on dialysis for end-stage renal disease

Demirer Asli Nar , Kemal Yasemin , Tutuncu Neslihan Bascil , Gursoy Alptekin , Demirag Nilgun Guvener

Objective: Our aim was to determine the prevalence and clinicopathological characteristics of thyroid cancers in the dialysis population and to evaluate potential risk factors.Design: We performed a retrospective analysis of our end-stage renal disease (ESRD) patients on dialysis and thyroidectomized patients without ESRD (2000–2006). Then we compared the data of thyroid cancer patients on dialysis (n=9) with the data of patients who had hist...

ea0014p34 | (1) | ECE2007

Ambulatory blood pressure reduction after rosiglitazone treatment in normotensive type 2 diabetic patients

Kemal Yasemin , Tutuncu Neslihan , Guvener Nilgun , Unal Asli , Atar Ilyas , Muderrisoglu Haldun

Objective: The thiazolidinediones are new and potentially useful developments in the treatment of type 2 diabetes and impaired glucose tolerance. We tested the effects of the thiazolidinedione, rosiglitazone on blood pressure in normotensive type 2 diabetes.Methods: After receiving approval from the local ethics committee, 25 normotensive diabetic patients were were enrolled to the study. Before the rosiglitazone treatment we measured plasma glucose, HbA...

ea0014p35 | (1) | ECE2007

Time dependent effects of rosiglitazone on heart and fluid dynamics: a 6-month follow up study

Kemal Yasemin , Demirag Nilgun , Tutuncu Neslihan , Yildirir Aylin , Atar Asli , Unal Asli

Objective: Thiazolidinediones (TZDs) have become a powerful tool for lowering insulin resistance. The problem of cardiovascular adverse events including fluid retention and risk of heart failure, although of a low incidence, should be well known and recognized. We aimed to evaluate the effects of rosiglitazone treatment on cardiac function and show whether these effects are reversible when we continued this treatment.Methods: Fourty-six type 2 diabetic p...